Effect on CYPs and prostaglandin activity
In this guide
In this guide
Author |
Test System |
Exposure |
Characterisation of test substance |
Main outcome measure |
Outcome |
Dugasani et al., 2010 |
Mouse leukaemic monocyte (RAW 264.7) |
1, 3 and 6 uM. |
[6]-gingerol, [8]-gingerol, [10]-gingerol |
compare the antioxidant and antiinflammatory |
Dose dependant inhibition of activated PGE2 release. Inhibition reached 58, 66, 73 and 87%, respectively, at 6uM. |
Jolad et al., 2004 |
HL-60 cells. |
Not specified. |
ginger constituents: gingerols, shogaols, 3-dihydroshogaols, gingerdiols. |
Effects of ginger components on LPS-induced PGE2 production. |
No cytotoxicity demonstrated. |
Jolad et al., 2005 |
HL-60 cells. |
Not specified. |
Ginger constituents containing gingerols, shogaols, 3-dihydroshogaols, gingerdiols. |
Effects of ginger components on LPS-induced PGE2 production. |
Inhibition of LPS-stimulated |
Kim et al., 2012 |
Human liver microsomes. |
0.05–5 ug/ml. |
Aqueous ethanolic ginger extract (30% EtOH). |
Inhibitory effect on CYP450-mediated drug metabolism. |
Concentration-dependent |
Kimura et al., 2010; |
Human CYP3A4 and CYP2C9 microsomes. |
Not specified. |
NA |
Inhibitory effect on CYP3A4 and CYP2C9 activity. |
significant inhibition of CYP3A4 IC50 5.1u g/ml or CYP2C9 IC50 (10ug/ml) activity. |
Lantz et al., 2007 |
U937 cells |
0.1 ug/ml for 6 hrs. |
Ginger extract and mixtures of 6-, 8- 10-gingerols and 6-, 8-, 10-shogaols. |
Effect on inflammatory |
No effect on COX-2 expression. |
Mukkavilli et al., 2014 |
Human liver microsomes. |
Ginger extract: 500 mg/ml (containing 15 mg/ |
Ginger extract: (containing 6-Gingerol, 8-Gingerol, 10-Gingerol, 6-Shogaol). All |
effect of ginger extract and major |
Inhibition of CYP1A2 (IC50 - |